Perspectives for adjuvant therapy.
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D005544:Forecasting; D006801:Humans; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D009369:Neoplasms / Q000191:economics / Q000601:surgery / Q000628:therapy*; D012306:Risk
D000970:Antineoplastic Agents